Edinburgh
University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma
October 30, 2024Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors
Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …
Researchers find Achilles’ heel protein in leukaemia
April 26, 2019Medical Communications AML, Edinburgh, Protein, YTHDF2, blood cancer, drug targets, leukaemia
An international team of researchers have identified an “Achilles’ heel” protein that could lead to the development of novel treatments …
Edinburgh researchers genetically modify chickens to produce medicine filled eggs
January 29, 2019Manufacturing and Production Edinburgh, cancer drugs, medicines, monoclonal antibodies, proteins
Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …
Latest content
Scots neonatal innovations target hearing loss and earlier care
August 28, 2026
Agentis Health Group acquires Clinical Pharmacist Solutions
August 26, 2026
